Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 26.02
-0.48 (-1.81%)
May 12, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 5.15 billion as of May 12, 2026. Its market cap has decreased by -3.63% in one year.
Market Cap
5.15B
Enterprise Value
5.94B
Revenue
1.46B
Ranking
n/a
PE Ratio
45.87
Stock Price
26.02
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 5.15B, a decrease of -36.76%. That is a compound annual growth rate of -8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 5.15B | -17.86% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition